Veraxa Biotech AG - Post de-SPAC VRXA Ratios (2024-2025)

NASDAQ VRXA
$1.00 -0.03 (-2.91%)
At close: Oct 23, 2026 · 4:00 PM EDT
Reported Financials

Veraxa Biotech AG - Post de-SPAC Quarterly Ratios

Periods 2 quarters
Latest Dec 2025

Veraxa Biotech AG - Post de-SPAC ratios data for the quarter ended Dec 2025. These financial ratios cover 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2024 Dec2025
Efficiency
Assets AverageAssets Avg. 98.03M
Equity AverageEquity Avg. -35.09M
Invested CapitalInvested Cap. -123.13M
Leverage & Solvency
Debt Ratio 0.01
Valuation
Price to BookP/B 2.60
Enterprise Value 134.69M150.88M
Market Capitalization 140.80M154.45M

Veraxa Biotech AG - Post de-SPAC Ratios API

Pull Veraxa Biotech AG - Post de-SPAC's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRXA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY